Status:
TERMINATED
Quality of Life for Patients With Chronic Paediatric Onset Inflammatory Bowel Disease (IBD)
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Crohn Disease
Ulcerative Colitis
Eligibility:
All Genders
12-24 years
Brief Summary
The main objective of the present study is to describe the quality of life of patients under 25 years of age with pediatric-onset IBD. The quality of life will be described according to the age and th...
Detailed Description
The continuous increase in incidence of chronic inflammatory bowel disease (IBD) will increase their burden on health care costs in the future. Pediatric IBD is frequently associated with an aggressiv...
Eligibility Criteria
Inclusion
- Male or female, between 12 and 24 years old included at the time of the study
- Subject listed in the EPIMAD registry suffering from certain or probable Crohn's disease, or certain or probable ulcerative colitis, or certain or probable ulcerative proctitis
- Disease diagnosed before the age of 17 (pediatric onset disease)
- Patient residing in the area of the EPIMAD register at the time of diagnosis: Nord, Pas-de-Calais, Somme or Seine-Maritime
- Patient not opposing the research
- Patient not having objected to the use of these data for ancillary studies when registering in the EPIMAD register
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
October 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2021
Estimated Enrollment :
298 Patients enrolled
Trial Details
Trial ID
NCT04881370
Start Date
October 9 2020
End Date
June 28 2021
Last Update
January 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Jeanne de Flandre Chu Lille
Lille, France, 59037